FDA-cleared profile

Synapse PACS (7.6.0)

FUJIFILM Healthcare Americas Corporation · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.

Clinical role
Medical-image management, viewing, measurement, and processing.
Images and patients
Radiological images; modality varies or is not specified in FDA list
Key limitation
MIP, MPR fusion, and volume rendering are not intended for mammography. Mammography use is limited to the described FUJIFILM DICOM MG For Processing workflow or lossless/non-compressed For Presentation images on FDA-cleared, DICOM-compatible mammography displays.

Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • Imaging and anatomyRadiological images; modality varies or is not specified in FDA list
  • Workflow roleMedical-image management, viewing, measurement, and processing.
  • Required inputImages from DICOM-compliant modalities and non-DICOM sources, together with medical information.
  • Output and human actionDisplayed, compared, fused, and volume-rendered studies; image measurements, regional segmentation, clinical calculations, and structured reports.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Synapse PACS 7.6.0 provides medical-image management and processing, including measurements, regional segmentation, clinical calculations, structured reports, comparison, fusion, and volume rendering to aid reading, interpretation, reporting, and treatment planning.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Medical-image management, viewing, measurement, and processing.
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Images from DICOM-compliant modalities and non-DICOM sources, together with medical information.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
Displayed, compared, fused, and volume-rendered studies; image measurements, regional segmentation, clinical calculations, and structured reports.
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Radiologists, cardiologists, technologists, sonographers, technicians, nurses, and clinicians.
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
MIP, MPR fusion, and volume rendering are not intended for mammography. Mammography use is limited to the described FUJIFILM DICOM MG For Processing workflow or lossless/non-compressed For Presentation images on FDA-cleared, DICOM-compatible mammography displays.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

The accessible extracted summary establishes identity and intended use. A complete performance abstraction and release-specific clinical validation were not established; the knee-template paper candidate does not validate PACS 7.6.0.

Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No release-specific disease-detection sensitivity with endpoint, population, and threshold was established from the material reviewed.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No release-specific disease-detection specificity with endpoint, population, and threshold was established from the material reviewed.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Images from DICOM-compliant modalities and non-DICOM sources, together with medical information.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · FDA 510(k) K261713: Synapse PACS (7.6.0)

  2. Routing

    Source context, not route validation: Web application on an off-the-shelf PC networked with a FUJIFILM Synapse PACS server; processes DICOM and non-DICOM sources.

    Scope: Exact FDA submission. Specific DICOM service classes, browser versions, EHR interfaces, and local compatibility require the release-specific conformance and integration documents.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · FDA 510(k) K261713: Synapse PACS (7.6.0)

  3. AI processing

    Source context, not route validation: Client/server web application using standard PC hardware and software that meets the manufacturer's minimum specifications.

    Scope: Exact product version. The reviewed text does not establish a current hosting contract or region.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · FDA 510(k) K261713: Synapse PACS (7.6.0)

  4. Returned objects

    Source context, not route validation: Displayed, compared, fused, and volume-rendered studies; image measurements, regional segmentation, clinical calculations, and structured reports.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · FDA 510(k) K261713: Synapse PACS (7.6.0)

  5. Viewer/worklist/report

    Unresolved route: Displayed, compared, fused, and volume-rendered studies; image measurements, regional segmentation, clinical calculations, and structured reports.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · FDA 510(k) K261713: Synapse PACS (7.6.0)

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Client/server web application using standard PC hardware and software that meets the manufacturer's minimum specifications.
  • Exact product version
  • Checked 2026-09-05

The reviewed text does not establish a current hosting contract or region.

Integration
Web application on an off-the-shelf PC networked with a FUJIFILM Synapse PACS server; processes DICOM and non-DICOM sources.
  • Exact FDA submission
  • Checked 2026-09-05

Specific DICOM service classes, browser versions, EHR interfaces, and local compatibility require the release-specific conformance and integration documents.

Web client and server

A standard PC web application is networked to a Synapse PACS server and can process DICOM and non-DICOM images.

exact product version · checked 2026-09-05

Current enterprise viewer offering

FUJIFILM describes a diagnostic viewer bringing radiology and mammography together with cardiology, pathology, and specialty-department data for on-site and remote clinicians.

product family · checked 2026-09-05

Current vendor offering; individual modules and capabilities are not all linked to K261713 or a 7.6.0 installation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K261713
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05

Controlled category retained for explicitly multimodality DICOM and non-DICOM inputs.

Anatomy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-05

The extracted FDA intended-use text describes general medical-image management without an exhaustive anatomy list. The catalog N/A placeholder is retained in the correction sidecar; it is not an exclusion of anatomical applications.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-18
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
26Fields reviewed
9Source classes checked
1Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored metadata screened. PMID 36224662 is a 2022 knee-arthroplasty template simulation study, not validation of the 2026 PACS 7.6.0 submission; not promoted. No stored trial candidates. Full text of that paper was not reviewed. The current discovery snapshot contains 1 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision material, vendor product page, literature index, trial registry, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Care setting: Not verified - checked 2026-09-05 - Exact FDA submission

    Enterprise medical-image use is described, but an exhaustive setting and age eligibility statement was not established in the extracted summary text.

  • Evidence summary: Not verified - checked 2026-09-05 - Exact FDA submission

    The accessible extracted summary establishes identity and intended use. A complete performance abstraction and release-specific clinical validation were not established; the knee-template paper candidate does not validate PACS 7.6.0.

  • Public pricing: Not verified - checked 2026-09-05 - Exact FDA submission

    The reviewed vendor product page provides no scoped 7.6.0 price. Obtain licensing unit, storage and migration charges, implementation, support, term, and optional-module costs; public procurement research is incomplete.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Fujifilm Synapse PACS reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-05 - Exact FDA submission

    No dated, scoped security attestation for this installed release and hosting arrangement was reviewed. Hosting region, PHI flow, retention, access controls, audit logging, and incident response remain to be confirmed.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-05 - Exact FDA submission

    Role-specific onboarding, mammography display training, and support commitments were not established for 7.6.0.

  • Monitoring: Not verified - checked 2026-09-05 - Exact FDA submission

    Release update control, local acceptance, downtime procedures, and incident escalation require a current vendor and site plan.

6 sources - 2 history items

Source ledger

  1. FDA 510(k) K261713: Synapse PACS (7.6.0)

    U.S. Food and Drug Administration - Published 2026-06-18 - Accessed 2026-09-05

    Scope: identity, clinicalUse, purpose, modality, input, output, limitations, integration, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. Synapse Radiology PACS product page

    FUJIFILM Healthcare Americas Corporation - Accessed 2026-09-05

    Scope: productFamilyWorkflow, implementationCapabilities

Research history

  1. K261713 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

Alternatives

Related tools to compare

FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29
FDA-cleared K260316

CMN Capillary Function with Oncology Virtual Expert

Cercare Medical A/S

Authorized purpose: Cercare Neurosuite with Capillary Function and Oncology Virtual Expert processes CT or MR information to provide perfusion, tissue-blood-volume, diffusion, labeling, and quantification support for adult brain glioma workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-06-22
FDA-cleared K252563

Neurophet SCALE PET

Neurophet., Inc.

Authorized purpose: Brain MRI/PET registration, segmentation and quantitative PET assessment

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-05-15

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history